BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2991733)

  • 1. Thymidylate synthase gene amplification in fluorodeoxyuridine-resistant mouse cell lines.
    Jenh CH; Geyer PK; Baskin F; Johnson LF
    Mol Pharmacol; 1985 Jul; 28(1):80-5. PubMed ID: 2991733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
    Berger SH; Jenh CH; Johnson LF; Berger FG
    Mol Pharmacol; 1985 Nov; 28(5):461-7. PubMed ID: 2932632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of thymidylate synthase enzyme synthesis in 5-fluorodeoxyuridine-resistant mouse fibroblasts during the transition from the resting to growing state.
    Jenh CH; Rao LG; Johnson LF
    J Cell Physiol; 1985 Jan; 122(1):149-54. PubMed ID: 3155521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of DNA sequences complementary to mouse thymidylate synthase messenger RNA.
    Geyer PK; Johnson LF
    J Biol Chem; 1984 Jun; 259(11):7206-11. PubMed ID: 6144683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of thymidylate synthetase and its inhibition by 5-fluorouracil in highly enzyme-overproducing cells resistant to 10-propargyl-5,8-dideazafolate.
    Danenberg KD; Danenberg PV
    Mol Pharmacol; 1989 Aug; 36(2):219-23. PubMed ID: 2528057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
    Wang W; Marsh S; Cassidy J; McLeod HL
    Cancer Res; 2001 Jul; 61(14):5505-10. PubMed ID: 11454699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the multiple 5' and 3' termini of poly(A)+ and poly(A)-deficient thymidylate synthase mRNA in growth-stimulated mouse fibroblasts.
    DeWille JW; Harendza CJ; Jenh CH; Johnson LF
    J Cell Physiol; 1989 Feb; 138(2):358-66. PubMed ID: 2918037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.
    Landis DM; Heindel CC; Loeb LA
    Cancer Res; 2001 Jan; 61(2):666-72. PubMed ID: 11212266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase mRNA expression does not predict resistance to floxuridine in a choriocarcinoma cell line.
    Han B; Xiang Y; Sha GH; Zhang H; Liu X
    J Reprod Med; 2010; 55(5-6):247-52. PubMed ID: 20626181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma.
    Baskin F; Carlin SC; Kraus P; Friedkin M; Rosenberg RN
    Mol Pharmacol; 1975 Jan; 11(1):105-17. PubMed ID: 123312
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered mouse leukemia L1210 thymidylate synthase, associated with cell resistance to 5-fluoro-dUrd, is not mutated but rather reflects posttranslational modification.
    Cieśla J; Fraczyk T; Zieliński Z; Sikora J; Rode W
    Acta Biochim Pol; 2006; 53(1):189-98. PubMed ID: 16505899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthetase overproduction in 5-fluorodeoxyuridine-resistant mouse fibroblasts.
    Rossana C; Gollakota Rao L; Johnson LF
    Mol Cell Biol; 1982 Sep; 2(9):1118-25. PubMed ID: 6217415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
    Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
    Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
    Washtien WL
    Mol Pharmacol; 1982 May; 21(3):723-8. PubMed ID: 6213845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
    Barbour KW; Hoganson DK; Berger SH; Berger FG
    Mol Pharmacol; 1992 Aug; 42(2):242-8. PubMed ID: 1355260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
    Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
    Berger SH; Barbour KW; Berger FG
    Mol Pharmacol; 1988 Oct; 34(4):480-4. PubMed ID: 2971872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA amplification in antifolate-resistant Leishmania. The thymidylate synthase-dihydrofolate reductase gene and abundant mRNAs.
    Washtien WL; Grumont R; Santi DV
    J Biol Chem; 1985 Jul; 260(13):7809-12. PubMed ID: 2409075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.
    Berger SH; Berger FG
    Mol Pharmacol; 1988 Oct; 34(4):474-9. PubMed ID: 2971871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase.
    Ayusawa D; Iwata K; Seno T
    Cancer Res; 1983 Feb; 43(2):814-8. PubMed ID: 6184158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.